Last reviewed · How we verify

NCT02593799

Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study

Completed Last updated 4 February 2019
What this trial tests

trial testing Endoscopy in Liver Cirrhosis in 363 participants. Completed in 31 December 2018.

Timeline
1 May 2015
Primary endpoint
31 December 2018
31 December 2018

Quick facts

Lead sponsorGeneral Hospital of Shenyang Military Region
StatusCompleted
Study typeOBSERVATIONAL
Enrollment363
Start date1 May 2015
Primary completion31 December 2018
Estimated completion31 December 2018
Sites17 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

General Hospital of Shenyang Military Region

Who can join

Eligibility, any sex, with Liver Cirrhosis or Esophageal and Gastric Varices. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Esophageal variceal bleeding is one of the most lethal complications of liver cirrhosis. In the early stage of liver cirrhosis, the prediction of esophageal varices is very important for guiding the clinical decision making of primary prophylaxis of variceal bleeding.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Liaoning Score for Prediction of Esophageal Varices in Cirrhotic Patients Who Had Never Undergone Endoscopy: A Multicenter Cross-Sectional Study in Liaoning Province, China.
    Qi X, Li Y, Wang R, Lin L, et al · · 2019 · cited 19× · PMID 31093864 · DOI 10.1007/s12325-019-00967-w

Verify or expand the search:

Other trials of Endoscopy

Trials testing the same drug.

Other recruiting trials for Liver Cirrhosis

Currently open trials in the same condition.

Other General Hospital of Shenyang Military Region trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02593799.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing